Status:
NOT_YET_RECRUITING
Ultra-processed Food Reducing Intervention and Continuous Glucose Monitoring
Lead Sponsor:
Korea University
Collaborating Sponsors:
Korean Society of Cardiometabolic Syndrome (funder)
Conditions:
Glycemic Variability
Postprandial Glucose
Eligibility:
All Genders
20-39 years
Phase:
NA
Brief Summary
The goal of this trial is to investigate whether reduction in ultra-processed food intake through diet counseling and education can improve postprandial glucose levels and glycemic variability among K...
Detailed Description
Diabetes is one of leading causes of mortality in Korean population. The increasing trend in diabetes prevalence is also observed among young Korean adults aged 19-29 years, imposing a substantial soc...
Eligibility Criteria
Inclusion
- Individuals whose ultra-processed food intake constitutes 25% or more of their total energy intake
- Individuals who are able to wear a continuous glucose monitoring device
- individuals who are willing to participate in follow-up assessments on a voluntary basis
Exclusion
- Individuals who have a personal history of diabetes or any glucose-related disorders
- Individuals with a risk of bleeding
- Individuals who have previously experienced side effects from continuous glucose monitoring device or who are unable to use the continuous glucose monitoring device
- Individuals who are unable to maintain continuous follow-up due to plans such as travel
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07175701
Start Date
October 1 2025
End Date
August 31 2026
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Promotion Lab, College of Health Science, Korea University
Seoul, Seoul, South Korea, 02841